Barclays Maintains Equal-Weight on Qiagen, Raises Price Target to $40

Benzinga Newsdesk www.benzinga.com Positive 76.4%

Neg 0% Neu 0% Pos 76.4%

Barclays analyst Luke Sergott maintains Qiagen (NYSE:QGEN) with a Equal-Weight and raises the price target from $38 to $40.